A new tool is now available to help hospitals, long-term care facilities, and certain outpatient facilities evaluate their best practices related to high-alert medications, identify opportunities for improvement, and track their experiences over time. Developed by the Institute for Safe Medication Practices (ISMP), the ISMP Medication Safety Self Assessment ® for High-Alert Medications focuses on general high-alert medications and 11 specific medication categories--including opioids, insulin, neuromuscular blocking agents, chemotherapy, and moderate and minimal sedation. Participants who submit assessment findings to
Read more